Subunit vaccines are safer than live-attenuated or inactivated vaccines. However, their limited immunogenicity and susceptibility to metabolic degradation require strong adjuvants and/or conjugation to delivery systems to induce a robust, antigen-specific immune response. Interestingly, synthetic peptides can be useful and polyvalent building blocks for development of self-adjuvanted nanoparticles. Recent studies showed that amphiphilic peptides can increase antigen density, promote cellular uptake by APCs and activate T and B lymphocytes. Additionally, short peptide monomers forming cross-β-sheet fibrils such as I10 have shown potential in inducing strong immunity against the grafted epitope. However, direct comparison of the intrinsic immunogenicity of peptide amphiphilic cylindrical micelles and cross-β peptide fibrils has never been performed. In this work, the amphiphilic peptide C16-V3A3K3(PA) and the I10 β-peptide were each linked to two epitope models, OVA253-266 and OVA323-339, able to polarize the resulting adaptive immune response differently. Biophysical analysis showed that both nanoplatforms formed β-sheet-rich nanofilament structures with epitopes exposed on their surfaces. Intramuscular administration in mice led to a strong, antigen-specific humoral response without additional adjuvants. This study illuminates the potential of synthetic self-assembling nanoplatforms as universal antigen carriers, enabling the rapid development of vaccines to combat infectious diseases.
Previous Article in event
Previous Article in session
Next Article in event
Next Article in session
Comparative study of the immunogenicity of two synthetic nanovaccines based on self-assembling peptides
Published:
16 November 2024
by MDPI
in 2nd Canadian Peptide and Protein Community Virtual Meeting
session Poster Session
Abstract:
Keywords: nanovaccines; adjuvant; peptide self-assembly; immune response; supramolecular structure